Please assess the completion status of the following clinical trial:

Trial Title: Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Confirmed diagnosis of Very long-chain acylCoA dehydrogenase (VLCAD) Deficiency, Carnitine Palmitoyltransferase 2 (CPT2) Deficiency, Mitochondrial Trifunctional Protein (TFP) Deficiency, or Long-chain 3 hydroxyacylCoA dehydrogenase (LCHAD) deficiency~* \> 7 years~* Ability to travel to CRC to participate~* Ability to follow protocol~Exclusion Criteria:~* Hgb \< 10 g/dl~* Peripheral neuropathy that limits ability to complete treadmill studies~* Inclusion in another research study that alters macronutrient intake~* Pregnant females~* history of myocardial infarction or cardiovascular disease

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Medium Chain Triglyceride (MCT) (Type: ACTIVE_COMPARATOR): Subjects randomized to consume 20% of energy from MCT
- Triheptanoin (Type: EXPERIMENTAL): Subject randomized to consume 20% of energy from triheptanoin.

Based on this trial design, predict the completion outcome and termination type (if applicable).